Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking & Finance Review

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2025 GBAF Publications Ltd - All Rights Reserved.

    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Headlines > Australia's Ramsay Health Care mulls potential sale of European arm
    Headlines

    Australia's Ramsay Health Care mulls potential sale of European arm

    Australia's Ramsay Health Care mulls potential sale of European arm

    Published by Global Banking and Finance Review

    Posted on February 27, 2025

    Featured image for article about Headlines

    By Rajasik Mukherjee

    (Reuters) - Ramsay Health Care has appointed Goldman Sachs to look at strategic options for its stake in its European division following an internal review, the Australian private hospital operator said on Thursday, hinting at a potential sale.

    The decision comes on the heels of management changes made earlier this year, including its group finance chief stepping down with a successor yet to be named and plans to boost the company's core Australian hospital business.

    The decision to explore options for Ramsay Sante, the European division, was "in line with the refocus of its strategy".

    "There are multiple factors that may influence timing and outcomes of this process. All strategic options need to take into account Ramsay Sante’s shareholding structure," Ramsay Health Care, the country's largest independent hospital operator, said in a statement.

    Sante, a private healthcare operator in Europe with its services spread across France, Italy, Norway, among others, has been underperforming for a while now. The division recorded a net loss of 43.1 million euros ($45.11 million) in its half-yearly results earlier this week.

    Ramsay Health Care owns around 52.8% of Ramsay Sante while Predica, a unit of French international banking group Credit Agricole, holds 39.8% of ownership.

    A potential divestment of Sante would bode well for Ramsay Health Care, said Luke Winchester, portfolio manager at Merewether Capital. "It has been a headache for management for some time, new executive team is in place and they have the opportunity to start fresh."

    The Australian parent reported it swung to a first-half net loss with poor results at Ramsay Sante and Elysium weighing on its bottom line.

    A sale could also see Ramsay returning some capital to shareholders, added Winchester.

    Ramsay's stock closed nearly 7% higher on Thursday, having risen as much as 16.7% earlier in the day, marking its best intraday percentage gain since April, 2022.

    ($1 = 0.9554 euros)

    (Reporting by Rajasik Mukherjee; Editing by Janane Venkatraman)

    Related Posts
    Novartis, Roche back US efforts to lower drug costs amid talk of pricing deal
    Novartis, Roche back US efforts to lower drug costs amid talk of pricing deal
    Saudi, French and U.S. officials push Hezbollah disarmament plan
    Saudi, French and U.S. officials push Hezbollah disarmament plan
    Russia sentences Briton who it says fought for Ukraine to 13 years in a prison camp
    Russia sentences Briton who it says fought for Ukraine to 13 years in a prison camp
    Ukrainian negotiators to meet US team on Friday, Saturday, Zelenskiy says
    Ukrainian negotiators to meet US team on Friday, Saturday, Zelenskiy says
    Court hearing adjourned in strangulation case involving UK's Duke of Marlborough
    Court hearing adjourned in strangulation case involving UK's Duke of Marlborough
    Ukraine says 180,000 consumers were left without power after Russian overnight attack
    Ukraine says 180,000 consumers were left without power after Russian overnight attack
    China says it is granting new, streamlined rare earth export licences
    China says it is granting new, streamlined rare earth export licences
    Romania to raise minimum wage by 6.8% from July
    Romania to raise minimum wage by 6.8% from July
    Coinbase appoints UK ex-finance minister George Osborne to run advisory council
    Coinbase appoints UK ex-finance minister George Osborne to run advisory council
    EU must reform or risk irrelevance, Blair and Dimon say
    EU must reform or risk irrelevance, Blair and Dimon say
    Russian attack on Ukraine's central Cherkasy injures six, causes blackouts, governor says
    Russian attack on Ukraine's central Cherkasy injures six, causes blackouts, governor says
    Europe's auto industry future may be electric even after EU climbdown
    Europe's auto industry future may be electric even after EU climbdown

    Why waste money on news and opinions when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Previous Headlines PostRussian delegation arrives for U.S. talks in Istanbul, witness says
    Next Headlines PostRussia extends gasoline export permits until end of Aug 2025, Ifax reports

    More from Headlines

    Explore more articles in the Headlines category

    Factbox-Can Ukraine survive without the EU's 'reparation loan'?

    Factbox-Can Ukraine survive without the EU's 'reparation loan'?

    EU leaders face crunch decision on using frozen Russian assets for Ukraine

    EU leaders face crunch decision on using frozen Russian assets for Ukraine

    Analysis-Return of 'Make Europe Great Again' trades hinges on German comeback

    Analysis-Return of 'Make Europe Great Again' trades hinges on German comeback

    Belarus' Lukashenko says US admission of failure to overturn re-election could revive relations

    Belarus' Lukashenko says US admission of failure to overturn re-election could revive relations

    Ukrainian drones kill three people in Russia's Rostov region, authorities say

    Ukrainian drones kill three people in Russia's Rostov region, authorities say

    Shares in South Korea's LGES drop more than 7% after Ford cancels EV battery deal

    Shares in South Korea's LGES drop more than 7% after Ford cancels EV battery deal

    Factbox-What we know about the shooting victims at Sydney's Bondi Beach Jewish event

    Factbox-What we know about the shooting victims at Sydney's Bondi Beach Jewish event

    Australia promises new hate laws as youngest Bondi Beach shooting victim is laid to rest

    Australia promises new hate laws as youngest Bondi Beach shooting victim is laid to rest

    UN, aid groups warn Gaza operations at risk from Israel impediments

    UN, aid groups warn Gaza operations at risk from Israel impediments

    IMF says Moldova's economy has unique growth opportunity, but reforms needed

    IMF says Moldova's economy has unique growth opportunity, but reforms needed

    UK firm Awendio Solaris plans $725 million solar plant with indigenous groups in Canada

    UK firm Awendio Solaris plans $725 million solar plant with indigenous groups in Canada

    AbbVie, several other pharma companies near MFN deal with Trump, sources say

    AbbVie, several other pharma companies near MFN deal with Trump, sources say

    View All Headlines Posts